Cell and Gene Commercialization
-
Development Of A Downstream Processing Platform For AAV
7/24/2023
There is a growing need for innovative solutions that reduce costs while maintaining high product quality. This poster presents investigations to derive an economic and scalable method for purification of AAV.
-
The Future Is Now: CGT Innovation, Challenges, And Perspectives
7/19/2023
As CGTs advance toward clinical trials, developers face a number of challenges such as navigating a shifting regulatory landscape and employing beneficial manufacturing processes.
-
An Expert Perspective On The State Of The Industry
7/19/2023
Review the current state of the cell and gene therapy industry as Tim Hunt, CEO of the Alliance for Regenerative Medicine (ARM), provides a briefing on the cell and gene therapy development landscape.
-
Advancing Cell And Gene Therapy Clinical Development In 2023
7/19/2023
Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.
-
The Price Is Right: CGT Approvals And Market Access In 2023
7/19/2023
Experts discuss strategies that balance value and benefit with affordability, collecting evidence to support broad approval, and how innovative payment schemes could help increase access to CGTs.
-
The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault
7/18/2023
Dr. Francois Vigneault, Co-Founder, President, and CEO at Shape Therapeutics joins Cell & Gene: The Podcast's Erin Harris to discuss how RNA technologies are shaping the future of gene therapy. They also discuss AI's role in gene therapy as well as how the CGT sector is benefiting from RNA, AI, and synthetic biology.
-
The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault
7/18/2023
How is RNA technology shaping the future of gene therapy? Find out the role AI is playing along with how new technologies are effecting the CGT sector.
-
Inside Prime Editing With Prime Medicine's Dr. Andrew Anzalone
7/6/2023
What is prime editing and why is it considered a major technological advancement in gene editing?
-
Prioritizing Speed In Drug Therapy Development And Moving Fast Safely
7/5/2023
Sponsors face pressure to balance speed, cost, and quality. Examine considerations to help you accelerate the delivery of transformative therapies while maintaining safety and upholding efficacy standards.
-
Improving Yield For Gene Therapy Through Transfection Optimization
7/4/2023
Examine the methods that hold potential for efficient gene therapy manufacturing and how achieving higher yields is crucial for making these treatments more accessible.